Proto Labs, Inc. (NYSE:PRLB) Stock Has Consensus Price Target of $100.50

Shares of Proto Labs, Inc. (NYSE:PRLB) have been given an average rating of “Moderate Buy” by the five ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $100.50.

PRLB has been the subject of several research reports. Benchmark increased their price target on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Proto Labs in a research report on Tuesday. Zacks Research downgraded shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 2nd. Weiss Ratings upgraded shares of Proto Labs from a “hold (c+)” rating to a “buy (b)” rating in a research note on Friday, October 16th. Finally, Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Saturday, July 18th.

Proto Labs Price Performance

NYSE PRLB traded up $1.15 on Tuesday, reaching $87.56. The company had a trading volume of 7,010 shares, compared to its average volume of 198,039. The business has a 50 day moving average of $86.47 and a two-hundred day moving average of $72.53. Proto Labs has a fifty-two week low of $45.10 and a fifty-two week high of $99.96. The firm has a market cap of $2.09 billion, a price-to-earnings ratio of 69.90 and a beta of 1.38.

Proto Labs (NYSE:PRLB) last announced its earnings results on Friday, July 31st. The industrial products company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.53 by $0.07. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%. The company had revenue of $149.34 million for the quarter, compared to analyst estimates of $144.53 million. During the same quarter in the prior year, the company earned $0.41 EPS. The firm’s revenue for the quarter was up 10.5% compared to the same quarter last year. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. As a group, research analysts predict that Proto Labs will post 1.46 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Daniel Schumacher sold 5,000 shares of the stock in a transaction on Thursday, September 24th. The stock was sold at an average price of $95.32, for a total transaction of $476,600.00. Following the transaction, the chief financial officer owned 35,019 shares of the company’s stock, valued at approximately $3,338,011.08. This represents a 12.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 10,000 shares of company stock worth $902,629. 1.30% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Fortitude Family Office LLC purchased a new stake in Proto Labs during the 3rd quarter worth approximately $40,000. Public Employees Retirement System of Ohio acquired a new position in Proto Labs in the 2nd quarter valued at about $37,000. Signaturefd LLC increased its stake in Proto Labs by 240.0% during the third quarter. Signaturefd LLC now owns 527 shares of the industrial products company’s stock worth $50,000 after acquiring an additional 372 shares during the last quarter. USA Financial Formulas purchased a new stake in shares of Proto Labs in the 1st quarter valued at approximately $52,000. Finally, GAMMA Investing LLC increased its holdings in Proto Labs by 9.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the industrial products company’s stock valued at $127,000 after purchasing an additional 118 shares during the last quarter. 84.54% of the stock is currently owned by hedge funds and other institutional investors.

Proto Labs Company Profile

Proto Labs, Inc (NYSE: PRLB), operating as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. The company uses automated quoting and manufacturing systems to help engineers and product developers produce custom parts without relying on traditional, lengthy tooling and procurement processes.

Protolabs offers computer numerical control (CNC) machining, injection molding, 3D printing and sheet-metal fabrication. Its services support the development and production of components in a range of materials and are used across industries including automotive, aerospace, medical, electronics and consumer products.

Founded in 1999 by entrepreneur Larry Lukis, the company has expanded its reach beyond its original U.S.